Glaxosmithkline
Covid-19 crisis: HUL hints at margin pressures, higher operating costs
Second-generation Covid-19 vaccines are built for impact over speed
J&J to begin human trials of Covid-19 vaccine in second half of July
GlaxoSmithKline Q4 consolidated net profit declines 6% to Rs 138 cr
Coronavirus vaccine not coming for at least 2 years: Novartis global CEO

GSK sells its entire 5.7% holding in HUL for over Rs 25,000 crore
GSK to offload HUL stake worth Rs 26,000 cr in largest secondary sale
GlaxoSmithKline plans sale of $3.7-billion stake in Hindustan Unilever
GlaxoSmithKline, Sanofi strike deal to develop coronavirus vaccine
Merger complete, focus now shifts to integration of HUL-GSK operations

GSK Consumer merger sets stage for Hindustan Unilever, Nestle face-off
Glaxo Consumer reports 6% rise in profit before tax for December quarter
GSK credits STEER for Horlicks technology after year-long IP battle